Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
6,430.00
5,616.00
5,664.00
3,624.00
4,400.00
3,462.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,430.00
5,616.00
5,664.00
3,624.00
4,400.00
3,462.00
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
103.00
127.00
-46.00
36.00
-273.00
Raw Materials Consumed
2,246.00
1,986.00
2,045.00
1,732.00
2,072.00
1,765.00
Power & Fuel Cost
202.00
199.00
229.00
124.00
95.00
74.00
Employee Cost
1,628.00
1,401.00
1,256.00
403.00
338.00
311.00
Operating Expenses
351.00
313.00
295.00
153.00
137.00
130.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
29.00
27.00
37.00
27.00
40.00
36.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
77.00
75.00
89.00
44.00
32.00
23.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
4,801.00
4,347.00
4,331.00
2,599.00
2,890.00
2,160.00
Operating Profit (PBDIT) excl Other Income
1,629.00
1,268.00
1,333.00
1,024.00
1,510.00
1,302.00
Other Income
316.00
213.00
170.00
240.00
223.00
134.00
Operating Profit (PBDIT)
1,945.00
1,482.00
1,503.00
1,265.00
1,734.00
1,437.00
Interest
33.00
42.00
26.00
7.00
5.00
3.00
Profit before Depriciation and Tax
1,912.00
1,440.00
1,477.00
1,257.00
1,728.00
1,433.00
Depreciation
423.00
377.00
344.00
146.00
110.00
98.00
Profit Before Taxation & Exceptional Items
1,488.00
1,062.00
1,132.00
1,111.00
1,618.00
1,334.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,464.00
1,062.00
1,132.00
1,054.00
1,618.00
1,334.00
Provision for Tax
437.00
364.00
360.00
273.00
406.00
337.00
Profit After Tax
1,027.00
698.00
772.00
781.00
1,211.00
996.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
7,156.00
6,787.00
6,015.00
5,234.00
4,022.00
3,025.00
Profit Available for appropriations
8,184.00
7,486.00
6,787.00
6,015.00
5,234.00
4,022.00
Appropriations
8,184.00
7,486.00
6,787.00
6,015.00
5,234.00
4,022.00
Equity Dividend (%)
2,000.00%
1,800.00%
2,000.00%
0.00%
0.00%
0.00%
Earnings Per Share
62.35
42.40
46.90
47.44
73.81
63.07
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 14.50% vs -0.85% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 28.42% vs -4.81% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -20.76% vs 60.31% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 47.07% vs -9.57% in Mar 2025
Compare Profit and Loss Results of Gland Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,430.00
5,452.00
978.00
17.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,430.00
5,452.00
978.00
17.94%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
37.00
-40.00
-108.11%
Raw Materials Consumed
2,246.00
1,146.00
1,100.00
95.99%
Power & Fuel Cost
202.00
73.00
129.00
176.71%
Employee Cost
1,628.00
1,291.00
337.00
26.10%
Operating Expenses
351.00
223.00
128.00
57.40%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
29.00
651.00
-622.00
-95.55%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
77.00
204.00
-127.00
-62.25%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
4,801.00
4,058.00
743.00
18.31%
Operating Profit (PBDIT) excl Other Income
1,629.00
1,394.00
235.00
16.86%
Other Income
316.00
172.00
144.00
83.72%
Operating Profit (PBDIT)
1,945.00
1,566.00
379.00
24.20%
Interest
33.00
16.00
17.00
106.25%
Profit before Depriciation and Tax
1,912.00
1,550.00
362.00
23.35%
Depreciation
423.00
173.00
250.00
144.51%
Profit Before Taxation & Exceptional Items
1,488.00
1,377.00
111.00
8.06%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,464.00
1,377.00
87.00
6.32%
Provision for Tax
437.00
321.00
116.00
36.14%
Profit After Tax
1,027.00
1,056.00
-29.00
-2.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
7,156.00
3,671.00
3,485.00
94.93%
Profit Available for appropriations
8,184.00
4,727.00
3,457.00
73.13%
Appropriations
8,184.00
4,727.00
3,457.00
73.13%
Equity Dividend (%)
2000%
1400%
600.00
Earnings Per Share
62.35
84.53
-22.18
-26.24%
Profit And Loss - Net Sales
Net Sales 6,430.65 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 14.50% vs -0.85% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,629.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 28.42% vs -4.81% in Mar 2025
Profit And Loss - Interest
Interest 33.28 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -20.76% vs 60.31% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 1,027.32 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 47.07% vs -9.57% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
